亚托皮炎和痴呆症之间的关联:从系统审查,元分析和孟德尔随机化中获得的证据
Yeon-Su Gwak1, Seo-Yeon Kim1, Chae-Eon Woo1
1School of Medicine, Pusan National University, Yangsan, Republic of Korea.
Acta dermato-venereologica
|January 3, 2025
概括
亚托皮炎与痴呆症有关,但因果关系尚未得到证实. 需要进一步的研究来理解这种复杂的关联.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 关于亚托皮性皮肤炎和痴呆症之间的关联,存在相互矛盾的证据.
- 亚托皮炎是一种慢性炎症性皮肤疾病,可能会影响全身健康,包括神经结果.
- 痴呆症包括各种神经退行性疾病,影响认知功能.
研究的目的:
- 通过系统性审查,元分析和门德尔随机化来研究亚托皮炎和痴呆症之间的关联.
- 确定亚托皮性皮肤炎是否是痴呆症及其亚型的因果风险因素.
主要方法:
- 在多个数据库 (Medline,Embase,Scopus,ScienceDirect,Web of Science) 进行系统的文献搜索.
- 使用逆变量加权 (IVW) 方法对5项纵向队列研究 (n=12,576,235) 的元分析.
- 使用基因组广泛关联研究 (GWAS) 数据进行门德尔随机化 (MR) 分析,用于阿托皮性皮炎和痴呆症.
主要成果:
- 分析显示,亚托皮性皮炎和全因性痴呆症之间存在显著的关联 (aHR:1.15,95%CI:1.07-1.23).
- 亚组分析表明与阿尔茨海默病 (aHR:1.18,95% CI:1.08-1.27) 和所有原因痴呆症的中度至严重的亚托皮炎 (aHR:1.37,95% CI:1.21-1.55) 的关联.
- 门德尔的随机化分析发现,亚托皮炎和痴呆症,阿尔茨海默病,血管痴呆症或认知表现之间没有显著的因果关系.
结论:
- 虽然观察数据表明存在关联,但门德尔的随机化不支持亚托皮炎和痴呆症之间的因果关系.
- 观察到的关联可能受到混因素或反向因果关系的影响.
- 需要进行进一步的研究,以探索人口统计学变量和药物效应在阿托皮性皮肤炎-痴呆症关系.
相关概念视频
Dementia
63
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
63
Alzheimer's Disease: Overview
311
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
311
Genome-wide Association Studies-GWAS
12.0K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.0K
Psychoneuroimmunology: Diabetes and Cancer
14
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
14
Human Genetics
469
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
469
Alzheimer's Disease: Treatment
125
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125


